4Kreuter J. Nanoparticulate systems for brain delivery of drugs [J]. Adv drugDeliv Rev, 2001, 47 (1): 65-81.
5Schroder U, Sommerfeld P, Ulrich S, et al. Nanoparticle technology for delivery of drugs across the blood - brain barrier [J]. J Pharm Sci, 1998, 87 (11): 1305-1307.
6Gulyaev AE, Gelperina SE, Skidn IN, et al. Significant transport of doxorubicin into the brain with polysorbate- 80 - coated nanoparticles [J]. Pharm Res, 1999, 16 (10): 1564-1669.
7Friese a, Seiller e, Quack G, et al. Increase of the duration of the anticonvulsive activity of a novel N M DA receptor antagonist using poly (butylcyanoacrylate) nanoparticles as a parenteral controlled release system [J]. Eur J Pharm Biopharm, 2000, 49(2): 103- 109.
10Shikata F, Tokumitsu H, Ichikawa H, et al. Invitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron - capture therapy of cancer [J]. Eur J Pharm Biopharm, 2002, 53 (1); 57-63.
7[1]BEGLEY DJ. The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system[J]. J Pharm Pharmacol, 1996,48(2):136-146.
8[2]KREUTER J, ALYAUTDIN RN, KHARKEVICH DA, et al. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) [J].Brain Res, 1995,647(1):171-174.
9[3]SCHRODER U, SABEL BA. Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of iv dalargin injections[J]. Brain Res, 1996,710(1-2):121-124.
10[4]SCHRODER U, SOMMERFELD P, ULRICH S, et al. Nanoparticle technology for delivery of drugs across the blood-brain barrier[J]. J Pharm Sci, 1998,87(11):1305-1307.
